Volv Global is pleased to be participating in the Life Sciences Innovation & Investment Corridor between Lausanne & London, hosted…
The idea that an AI system could detect a disease that appears nowhere in a patient's medical record sounds like…
The ISPOR International Annual Conference 2026 brings together global leaders in health economics and outcomes research to explore the future…
Photos from Digital Lounge @Davos. Volv Global CEO and founder Christopher Rudolf has been…
Artificial intelligence continues to redefine clinical development yet much of the conversation remains driven by hype rather than hard evidence.…
Volv Global continues to shape the future of AI in healthcare. This November, at Frontiers Health 2025 in Berlin, CEO…
Léon van Wouwe, Clinical Innovation Director, Volv Global Since Volv Global first started attending the World Orphan Drug Congress, we…
Introduction Artificial intelligence continues to push healthcare into a new era from early disease detection to large-scale data modelling. Yet…
How AI-driven insights from RWD accelerate the diagnosis and treatment of undiagnosed patients: A case study in alpha-1 antitrypsin deficiency…
Volv Global at WODC Europe 2025 - Where Technology Meets Human Volv Global sits at the crucial intersection between technology…